The CannaPlan employee benefit provides a unique platform that allows for the substitution of prescription medications with cannabis where appropriate. The potential rescheduling of cannabis to Schedule III directly influences this benefit, rendering it eligible for pre-tax medical benefits not typically covered by conventional health insurance plans. By empowering employees to choose between prescription drugs and cannabis, companies can realistically reduce healthcare premiums through the implementation of CannaPlan. The Prezi presentation slated for FMCEE is strategically crafted to enlighten employers, particularly physicians who own practices in this domain. The information presented is equally valuable to other employers in attendance, including those from dispensaries. The presentation aims to shed light on how insurance companies allocate healthcare premium costs for prescription drugs and will delve into specific cost-saving examples by comparing them to applicable prescriptions. Additionally, the presentation will provide insights into the CannaPlan program, featuring workshops designed to educate employees on cannabinoids. It will illustrate how prescription drugs can be replaced with cannabinoids for certain ailments, with a particular emphasis on pain medication, anxiety, and depression. The exorbitant cost of pharmaceuticals for these conditions significantly impacts a company's healthcare premiums, and the adoption of cannabis as an alternative can effectively mitigate these costs.